Nuo Therapeutics, Inc. (AURX)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch AURX
See up to 3 months of AURX. The 7-day demo opens the 1M and 3M ranges and puts AURX on your watchlist.
Start 7-day demoLatest AURX insider trades
About Nuo Therapeutics, Inc. (AURX)
The SEC lists Nuo Therapeutics, Inc. under CIK 0001091596, in surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
AURX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 8,773 | $10K |
| Grant or award | 4 | 13,731 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AURX insider transactions (Form 4)
5119 Form 4 filings on record, the earliest from Nov 19, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Scott M. Pittman - Director | Grant or award | Second Restated Warrant (right to buy) | 4,500 | $1.50 | $7K | |
| Scott M. Pittman - Director | Grant or award | Prepayment Restated Warrant (right to buy) | 458 | $1.50 | $687 | |
| David Emerson Jorden - Officer | Open-market purchase | Common Stock | 789 | $1.07 | $844 | |
| David Emerson Jorden - Officer | Open-market purchase | Common Stock | 7,984 | $1.09 footnote F1 | $9K | |
| ||||||
| David Emerson Jorden - Officer | Grant or award | Common Stock | 789 | $1.07 | $844 | |
| David Emerson Jorden - Officer | Grant or award | Common Stock | 7,984 | $1.09 footnote F1 | $9K | |
| ||||||
| Peter Clausen - Officer | Grant or award | Option to purchase common stock | 65,000 | $0.00 | - | |
| David Emerson Jorden - Officer | Option exercise | Common Stock | 162,500 | $1.00 | $163K | |
| David Emerson Jorden - Officer | Tax withholding / forfeiture | Common Stock | 160,892 | $1.01 | $163K | |
| David Emerson Jorden - Officer | Option exercise | Option to purchase common stock | 162,500 | $0.00 | - | |
| David Emerson Jorden - Officer | Grant or award | Option to purchase common stock | 125,000 | $0.00 | - | |
| Scott M. Pittman - Director | Option exercise | Common Stock | 40,000 | $1.00 | $40K | |
| Scott M. Pittman - Director | Tax withholding / forfeiture | Common Stock | 39,604 | $1.01 | $40K | |
| Scott M. Pittman - Director | Option exercise | Option to purchase common stock | 40,000 | $0.00 | - | |
| Scott M. Pittman - Director | Grant or award | Option to purchase common stock | 30,000 | $0.00 | - | |
| C. Eric Winzer - Director | Option exercise | Common Stock | 40,000 | $1.00 | $40K | |
| C. Eric Winzer - Director | Tax withholding / forfeiture | Common Stock | 39,604 | $1.01 | $40K | |
| C. Eric Winzer - Director | Option exercise | Option to purchase common stock | 40,000 | $0.00 | - | |
| C. Eric Winzer - Director | Grant or award | Option to purchase common stock | 30,000 | $0.00 | - | |
| Paul Mintz - Director | Grant or award | Option to Purchase Common Stock | 30,000 | $0.00 | - | |
| David Emerson Jorden - Officer | Grant or award | Common Stock | 13,245 | $1.10 footnote F1 | $15K | |
| ||||||
| Scott M. Pittman - Director | Grant or award | Initial Warrant (right to buy) | 30,050 | $1.50 | $45K | |
| Scott M. Pittman - Director | Grant or award | Second Warrant (right to buy) | 36,750 | $1.50 | $55K | |
| Scott M. Pittman - Director | Grant or award | Prepayment Warrant (right to buy) | 7,516 | $1.50 | $11K | |
| Scott M. Pittman - Director | Grant or award | Commitment Warrants (right to buy) | 2,050 | $1.50 | $3K | |
| Scott M. Pittman - Director | Grant or award | Origination Initial Warrants (right to buy) | 1,333 | $1.50 | $2K | |
| Scott M. Pittman - Director | Grant or award | Capital Initial Warrants (right to buy) | 26,667 | $1.50 | $40K | |
| Scott M. Pittman - Director | Grant or award | Origination Second Warrants (right to buy) | 1,750 | $1.50 | $3K | |
| Scott M. Pittman - Director | Grant or award | Capital Second Warrants (right to buy) | 35,000 | $1.50 | $53K | |
| Scott M. Pittman - Director | Grant or award | Prepayment Warrants (right to buy) | 7,516 | $1.50 | $11K | |
| David Emerson Jorden - Officer | Open-market sale | Common Stock | 200,000 | $1.50 | $300K | |
| Charles E. Sheedy - 10% Owner | Open-market purchase | Common Stock | 133,333 | $1.50 | $200K | |
| Paul Mintz - Director | Option exercise | Common Stock | 87,500 | $0.40 | $35K | |
| Paul Mintz - Director | Tax withholding / forfeiture | Common Stock | 20,115 | $1.74 | $35K | |
| Paul Mintz - Director | Option exercise | Option to purchase common stock | 87,500 | $0.00 | - | |
| David Emerson Jorden - Officer | Option exercise | Common Stock | 100,000 | $0.40 | $40K | |
| David Emerson Jorden - Officer | Option exercise | Common Stock | 92,710 | $0.40 | $37K | |
| David Emerson Jorden - Officer | Tax withholding / forfeiture | Common Stock | 21,313 | $1.74 | $37K | |
| David Emerson Jorden - Officer | Option exercise | Option to purchase common stock | 192,710 | $0.00 | - | |
| C. Eric Winzer - Director | Option exercise | Common Stock | 120,313 | $0.40 | $48K | |
| C. Eric Winzer - Director | Tax withholding / forfeiture | Common Stock | 27,659 | $1.74 | $48K | |
| C. Eric Winzer - Director | Option exercise | Option to purchase common stock | 120,313 | $0.00 | - | |
| Peter Clausen - Officer | Option exercise | Common Stock | 183,853 | $0.40 | $74K | |
| Peter Clausen - Officer | Option exercise | Option to purchase common stock | 183,853 | $0.00 | - | |
| Scott M. Pittman - Director | Grant or award | Common Stock | 3,946 | $1.50 | $6K | |
| Scott M. Pittman - Director | Option exercise | Common Stock | 121,875 | $0.40 | $49K | |
| Scott M. Pittman - Director | Option exercise | Common Stock | 62,500 | $0.40 | $25K | |
| Scott M. Pittman - Director | Option exercise | Common Stock | 33,334 | $0.50 | $17K | |
| Scott M. Pittman - Director | Option exercise | Option to Purchase Common Stock | 121,875 | $0.00 | - | |
| Scott M. Pittman - Director | Option exercise | Option to Purchase Common Stock | 62,500 | $0.00 | - | |
| Scott M. Pittman - Director | Option exercise | Option to Purchase Common Stock | 33,334 | $0.00 | - | |
Item 1.01, 2.03, 3.02, 9.01
Item 2.02, 9.01
Item 1.01, 2.03, 3.02, 9.01
Item 2.02, 9.01
AURX insider trading FAQ
What is the latest insider trade for AURX?
Nuo Therapeutics, Inc. (AURX) had 3 insider filings in the last 90 days, with the most recent on 2026-10-06. The full record for AURX runs to 19 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AURX stock?
2 insider purchases of AURX were filed in the last 90 days, totaling $10K.
How many insiders are selling AURX stock?
No insider sales of AURX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see AURX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AURX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Scott M. Pittman view on EDGAR
- - David Emerson Jorden view on EDGAR
- - David Emerson Jorden view on EDGAR
- - Peter Clausen view on EDGAR
- - David Emerson Jorden view on EDGAR
- - Scott M. Pittman view on EDGAR
- - C. Eric Winzer view on EDGAR
- - Paul Mintz view on EDGAR
- - David Emerson Jorden view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where AURX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AURX with a 7-day demo
- AURX on your watchlist
- Every AURX Form 4 filing on record
- Up to 3 months of AURX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
